Search

everythinglearnresearchcommunity

for

Search:↓

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Platelet-Rich Plasma (PRP) can improve hair loss in cicatricial alopecia cases, but treatment must be ongoing and results vary among patients.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Trichoscopy helps tell different hair loss types apart using specific scalp and hair patterns.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Keeping radiation doses under 16 Gy may reduce permanent hair loss.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Radiation-induced alopecia after angioembolization usually heals on its own and can look like other hair loss types, but patient history helps prevent misdiagnosis.

Hair loss from mood stabilizers can grow back, but the reasons why are not fully understood.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Potential therapeutic targets for scarring hair loss are identified.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Hair follicle counts and ratios are helpful in diagnosing hair loss types, but should be used with other specific features for accurate diagnosis.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Mesotherapy for hair loss can sometimes cause more hair loss and scarring.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Many alopecia patients have undetected thyroid abnormalities that can be found through physical exams.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Friction from socks or shoes can cause long-lasting hair loss on lower legs.